In Brief: Genzyme's Cerezyme
Executive Summary
Genzyme's Cerezyme: Allston Landing plant in Boston approved by FDA for manufacture of the recombinant glucocerebrosidase product. Genzyme will begin to ship drug supplies from the plant by year end. Cerezyme has been available in very limited supply since its approval in 1994, with 90% of the 1,700 Gaucher's disease patients being treated with enzyme replacement still receiving the nonrecombinant glucocerebrosidase Ceredase...